Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-28T03:00:55.932Z Has data issue: false hasContentIssue false
  • English
  • Français

Hepatitis B Vaccine—A Boon for Whom?

Published online by Cambridge University Press:  02 January 2015

Bruce H. Hamory
Bruce H. Hamory*
Affiliation:
Department of Medicine, Hospital Epidemiologist, University of Missouri Health Science Center, Columbia, Missouri
*
Department of Medicine, Hospital Epidemiologist, University of Missouri Health Science Center, Columbia, MO 65212
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial Series: Hepatitis B Vaccine
Information
Infection Control & Hospital Epidemiology , Volume 3 , Issue 5 , October 1982 , pp. 372 - 373
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1982

References

1. Krugman, S: The newly licensed hepatitis B vaccine — Characteristics and indications for use. JAMA 1982;247:2012–2015.Google Scholar
2. Dienstag, JL: Toward the control of hepatitis B. N Engl J Med 1980;303:874–76.CrossRefGoogle ScholarPubMed
3. Hirschowitz, BA, Dasher, CA, Whitt, FJ, et al: Hepatitis B antigen and antibody and tests of liver function — A prospective study of 310 hospital laboratory workers. Am J Clin Pathol 1980;73:63–68.CrossRefGoogle ScholarPubMed
4. Craig, CP, Gribble, C, Suarez, K: Risk of hepatitis B among phlebotomists. Am J Infect Control 1981;9:11–14.CrossRefGoogle ScholarPubMed
5. Hepatitis Surveillance Report No. 47. Atlanta, Centers for Disease Control. December, 1981, p 3.Google Scholar
6. Purcell, RH, Gerin, JL: Hepatitis B vaccines. On the threshold. Am J Clin Pathol 1978;70:159–169.Google Scholar
7. Kapikian, AZ, Mitchell, RH, Chanock, RM, et al: An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS vaccine. Am J Epidemiol 1969;89:405–421.CrossRefGoogle ScholarPubMed
8. Smith, CB, Friedwald, WT, Chanock, RM: Inactivated M. pneumonia vaccine. Evaluation in volunteers. JAMA 1979;199:353–358.CrossRefGoogle Scholar
9. Fulginiti, VA, Eller, JJ, Downie, AW, et al. Altered reactivity to measles virus: A typical measles in children previously immunized with inactivated measles virus vaccines. JAMA 1967;202:1075–1080.Google Scholar
10. Szmuness, W, Stevens, CE, Harley, EJ, et al: Hepatitis B vaccine. Demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med 1980;303:833–841.Google Scholar
11. Pattison, CP, Maynard, E, Berquist, KR, et al: Epidemiology of hepatitis B in hospital personnel. Am J Epidemiol 1975;101:59–64.CrossRefGoogle ScholarPubMed